Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Quick Stats
Jan 30, 202652.7
AI Score
HOLD0.65
Volume Ratio
Feb 25, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
RLAY Stock Summary
Last updated Jan 30, 2026
RLAY is currently trading at $7.66, positioned above its 200-day moving average of $5.09, indicating a long-term uptrend. The stock has a 52-week range of $1.775 to $9.04.
Technical Analysis: The 50-day moving average stands at $7.85, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 47.553, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.256, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RLAY at 52.7/100 with a HOLD recommendation.
RLAY (Relay Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 47.553 |
| CMF (20) | -0.256 |
| ROC (10) | 0.393 |
| ADX (14) | 15.609 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.056 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -60.0 |
| MFI (14) | 47.598 |
RLAY Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RLAY Price vs Max Options Open Interest
RLAY Max Change In Options Open Interest
RLAY Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RLAY Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RLAY Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RLAY Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Relay Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
RLAY Moving Averages Analysis
Relay Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
RLAY (Relay Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 7.64 |
| 20 | 7.81 |
| 30 | 8.0 |
| 50 | 7.85 |
| 100 | 6.84 |
| 200 | 5.09 |
RLAY Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.3 billion |
| Earnings/Share ($) | -1.72 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.7426 |
| EPS Estimate Next Year ($) | -1.6377 |
| WallStreet Target Price ($) | 14.5455 |
| Most Recent Quarter |